Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Calevia Inc. to Develop Graphene-based, Non-Invasive Cancer Eradication Therapies in Partnership with Grafoid Inc. and ProScan Rx Pharma Inc.

Abstract:
ProScanRxPharma Inc. and Grafoid Inc announced today the formation of Calevia Inc., an entirely new cancer therapeutic nanotechnology platform for the precise targeting and thermal eradication of solid tumors.

Calevia Inc. to Develop Graphene-based, Non-Invasive Cancer Eradication Therapies in Partnership with Grafoid Inc. and ProScan Rx Pharma Inc.

Montreal, Canada | Posted on September 7th, 2013

Calevia intends to combine ProScan's cellular antibody targeting technologies with MesoGraf™Xide graphene supplied by Grafoid Inc. to eradicate cancerous cells in a non-invasive manner.

Mesograf™ Xide is a unique, functionalized, photoresponsive graphene material that may be coupled with ProScan' s selective molecular targeting antibody ligands to create a photothermal bio-conjugate for the treatment of prostate cancer. Grafoid's Mesograf™ derivative Mesograf™Xide is the latest development in thermal energy generating nanomaterial science that instantly transforms near infrared (NIR) light into heat.

As a result of targeting, the heat generating bio-conjugate is delivered selectively to tumor cells and remotely activated by harmless NIR light to safely and effectively destroy cancer tissue from within in a physically powerful way, heat. Calevia's targeted photothermal therapy may overcome the side effects and strong limitations of common therapeutic methods such as surgery, radiation and chemotherapy.

Focal therapy is the focus of significant development by the pharmaceutical industry. Calevia believes that photothermal therapy using heat as the treatment modality represents a very innovative approach to focal cancer treatment. Calevia will first target prostate cancer using Proscan's anti-PSMA antibody. The platform will be developed subsequently for several solid tumor types.

Dr Vezeau, co-founder of Calevia said the combination of cell targeting at the molecular level with Grafoid's MesoGraf™Xide could ultimately redefine the way medicine treats several forms of solid tumors. "That is our goal."

He added that Calevia's targeted photothermal treatment opens the door to an entirely new therapeutic platform that overcomes the deficiencies inherent in traditional therapies.

"Targeting the photothermal ablation of prostate and subsequently other solid cancers bridges the gap between conventional therapies and today's nanotechnology revolution," Dr. Vezeau said.

Calevia's co-founders Dr. Claude Vezeau serves as President and CEO, and Dr. Serge Moffett serves as Vice-President, Research and Development. Dr. Gordon Chiu, B.Sci., M.Sci., f-M.S.T.P., N.D. and Vice-President of Grafoid Inc., serves as co-manager and advisor to the project.

Grafoid Inc. has invested in Calevia Inc. and will co-manage the early stage venture. Grafoid is also involved with the arrangement of Calevia's next stage and longer-term financing.

Dr. Vezeau will be presenting Calevia at the Rodman & Renshaw Global Investment Conference in New York, September 8-10, 2013.

About ProScanRxPharma Inc.

ProScanRxPharma Inc. is an experienced developer of targeted monoclonal antibodies. ProScan is dedicated to the development of innovative solutions to improve and simplify the clinical management of patients suffering from prostate cancer. It applies modern technologies to develop new molecular tools to provide clinicians and their cancer patients with efficient diagnostic and treatment alternatives. ProScan's products are expected to bring a new wave of solutions to clinicians and patients for the safer and more efficient detection and control of prostate cancer.

About Grafoid Inc.

Grafoid Inc. is a privately held Canadian corporation investing in graphene applications and economically scalable production processes for MesoGraf™ - the global standard for graphene - and MesoGraf™Xide its trade mark graphene oxide produced from raw, unprocessed graphite ore. Focus Graphite Inc. (TSX VENTURE:FMS)(OTCQX:FCSMF)(FRANKFURT:FKC) holds a principal interest in Grafoid on behalf of its shareholders.

Forward Looking Statements - Disclaimer

This news release may contain forward looking statements, being statements which are not historical facts, and discussions of future plans and objectives. There can be no assurance that such statements will prove accurate. Such statements are necessarily based upon a number of estimates and assumptions that are subject to numerous risks and uncertainties that could cause actual results and future events to differ materially from those anticipated or projected.

####

For more information, please click here

Contacts:
ProScanRxPharma Inc.
Dr. Claude Vezeau
514-908-0660

www.proscanrxpharma.com
www.calevia.com

Grafoid Inc.
Dr. Gordon Chiu
Vice-President
613-691-1091 ext 104

www.grafoid.com

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Color effects from transparent 3D printed nanostructures: New design tool automatically creates nanostructure 3D print templates for user-given colors Scientists present work at prestigious SIGGRAPH conference August 18th, 2018

Novel nanoparticle-based approach detects and treats oral plaque without drugs August 17th, 2018

UVA multidisciplinary engineering team designs technology for smart materials: The invention could lead to devices and manufactured goods, such as fabrics, that can dynamically regulate between thermally insulating and cooling August 17th, 2018

Smallest transistor worldwide switches current with a single atom in solid electrolyte: Milestone of energy efficiency in information technology -- Publication in Advanced Materials August 17th, 2018

Graphene/ Graphite

CTI Materials drives nano commercialization with it's patented surfactant free nanoparticle dispersions August 15th, 2018

Flipping the switch on supramolecular electronics August 14th, 2018

Quantum chains in graphene nanoribbons: Breakthrough in nanoresearch August 9th, 2018

Nanotube 'rebar' makes graphene twice as tough: Rice University scientists test material that shows promise for flexible electronics August 3rd, 2018

Nanomedicine

Novel nanoparticle-based approach detects and treats oral plaque without drugs August 17th, 2018

Research brief: UMN researchers use green gold to rapidly detect and identify harmful bacteria August 15th, 2018

New technology can detect hundreds of proteins in a single sample: Improvement of barcoding technique offers cost-effective alternative to current technology August 13th, 2018

Scientists squeeze nanocrystals in a liquid droplet into a solid-like state and back again: Simple chemical technique transforms crystal mixture where 2 liquids meet August 9th, 2018

Announcements

Color effects from transparent 3D printed nanostructures: New design tool automatically creates nanostructure 3D print templates for user-given colors Scientists present work at prestigious SIGGRAPH conference August 18th, 2018

Novel nanoparticle-based approach detects and treats oral plaque without drugs August 17th, 2018

UVA multidisciplinary engineering team designs technology for smart materials: The invention could lead to devices and manufactured goods, such as fabrics, that can dynamically regulate between thermally insulating and cooling August 17th, 2018

Smallest transistor worldwide switches current with a single atom in solid electrolyte: Milestone of energy efficiency in information technology -- Publication in Advanced Materials August 17th, 2018

Events/Classes

Kavli Lectures: New vision of nanomaterial synthesis and light-fueled space travel August 8th, 2018

Nanoscience and the future of healthcare kick off first day of ACS national meeting in Boston: Presidential events highlight safety, diversity and groundbreaking research August 2nd, 2018

Leti & CMP Announce World’s First Multi-Project-Wafer Service with Integrated Silicon OxRAM: Oxide-Based Resistive Ram Memory Platform Development for Backend Memories To Offer Non-Volatility Associated with Embedded Designs August 2nd, 2018

Strategic Materials Conference 2018 Highlights “Materials Shaping the Future of Electronics” July 30th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project